Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17511386rdf:typepubmed:Citationlld:pubmed
pubmed-article:17511386lifeskim:mentionsumls-concept:C0011644lld:lifeskim
pubmed-article:17511386lifeskim:mentionsumls-concept:C1705483lld:lifeskim
pubmed-article:17511386lifeskim:mentionsumls-concept:C1407029lld:lifeskim
pubmed-article:17511386pubmed:issue3lld:pubmed
pubmed-article:17511386pubmed:dateCreated2007-5-21lld:pubmed
pubmed-article:17511386pubmed:abstractTextThe name scleroderma is given to a spectrum of diseases which differ clinically and bear different prognostic risks. The origins of the various forms of the disease are unclear. A toxic influence has been suggested, particularly for the progressive systemic scleroderma. However, the imputability of the suspected chemicals often remains unsettled.lld:pubmed
pubmed-article:17511386pubmed:languagefrelld:pubmed
pubmed-article:17511386pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17511386pubmed:citationSubsetIMlld:pubmed
pubmed-article:17511386pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17511386pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17511386pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17511386pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17511386pubmed:statusMEDLINElld:pubmed
pubmed-article:17511386pubmed:monthMarlld:pubmed
pubmed-article:17511386pubmed:issn0370-629Xlld:pubmed
pubmed-article:17511386pubmed:authorpubmed-author:PiérardG EGElld:pubmed
pubmed-article:17511386pubmed:authorpubmed-author:Piérard-Franc...lld:pubmed
pubmed-article:17511386pubmed:authorpubmed-author:PaquetPPlld:pubmed
pubmed-article:17511386pubmed:authorpubmed-author:QuatresoozPPlld:pubmed
pubmed-article:17511386pubmed:issnTypePrintlld:pubmed
pubmed-article:17511386pubmed:volume62lld:pubmed
pubmed-article:17511386pubmed:ownerNLMlld:pubmed
pubmed-article:17511386pubmed:authorsCompleteYlld:pubmed
pubmed-article:17511386pubmed:pagination170-4lld:pubmed
pubmed-article:17511386pubmed:meshHeadingpubmed-meshheading:17511386...lld:pubmed
pubmed-article:17511386pubmed:meshHeadingpubmed-meshheading:17511386...lld:pubmed
pubmed-article:17511386pubmed:meshHeadingpubmed-meshheading:17511386...lld:pubmed
pubmed-article:17511386pubmed:meshHeadingpubmed-meshheading:17511386...lld:pubmed
pubmed-article:17511386pubmed:meshHeadingpubmed-meshheading:17511386...lld:pubmed
pubmed-article:17511386pubmed:meshHeadingpubmed-meshheading:17511386...lld:pubmed
pubmed-article:17511386pubmed:meshHeadingpubmed-meshheading:17511386...lld:pubmed
pubmed-article:17511386pubmed:meshHeadingpubmed-meshheading:17511386...lld:pubmed
pubmed-article:17511386pubmed:meshHeadingpubmed-meshheading:17511386...lld:pubmed
pubmed-article:17511386pubmed:meshHeadingpubmed-meshheading:17511386...lld:pubmed
pubmed-article:17511386pubmed:year2007lld:pubmed
pubmed-article:17511386pubmed:articleTitle[How I explore...the revisited toxic path of scleroderma].lld:pubmed
pubmed-article:17511386pubmed:affiliationCHU du Sart Tilman, Service de Dermatopathologie, Liège, Belgique. pascale.quatresooz@chu.ulg.ac.belld:pubmed
pubmed-article:17511386pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17511386pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:17511386pubmed:publicationTypeReviewlld:pubmed